Craig McGlashan

‘Contrary to popular belief, our belief is that there's a pretty strong manufacturing base across all of Europe,’ said Ewen.

Proteros Biostructure is a founder-led contract research organisation that focuses on early-stage drug discovery.

Proteros focuses on early-stage drug discovery and works with companies in Europe, the US and Japan.

‘Businesses are increasingly choosing to digitise fleet operations to cope with rising labour and fuel costs, adapt to the electrification of fleets and manage compliance in an ever-changing regulatory environment,’ said Battery’s Zak Ewen.

'We have always focused on companies with less debt financing and this prudent approach pays off during periods of recession,' said de Klerk.

Good morning Eurohubsters, Craig McGlashan here with the Dealflow. It’s great to see that the start of the year has opened with some nice deals, even if there is still pessimism around just how large dealmaking volumes will be in 2023. We reflect that today, with a tech-focused outlook from EQT, insight on the year […]

"We will see the crown jewel assets continue to attract premium valuations, given their scarcity."

Amey is a contractor to the UK government and public sector and its core markets are transport, infrastructure and government buildings.

Rockpool Investments exited its investment in Fortus Group, a provider of security equipment and monitoring services.

Advent is taking space company Maxar Technologies private in a $6.4 billion deal.